481 related articles for article (PubMed ID: 33117375)
1. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
Huang H; Deng Z
Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
[TBL] [Abstract][Full Text] [Related]
3. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
4. Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry.
Piché C; Béland K; Lapierre P; Massie B; Alvarez F
Liver Int; 2011 Oct; 31(9):1306-14. PubMed ID: 22093453
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
[TBL] [Abstract][Full Text] [Related]
7. Immune mechanisms of Concanavalin A model of autoimmune hepatitis.
Wang HX; Liu M; Weng SY; Li JJ; Xie C; He HL; Guan W; Yuan YS; Gao J
World J Gastroenterol; 2012 Jan; 18(2):119-25. PubMed ID: 22253517
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.
Yüksel M; Laukens D; Heindryckx F; Van Vlierberghe H; Geerts A; Wong FS; Wen L; Colle I
Int J Exp Pathol; 2014 Oct; 95(5):309-20. PubMed ID: 25112417
[TBL] [Abstract][Full Text] [Related]
9. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
10. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
11. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.
Lapierre P; Béland K; Yang R; Alvarez F
Hepatology; 2013 Jan; 57(1):217-27. PubMed ID: 22911361
[TBL] [Abstract][Full Text] [Related]
12. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
14. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
15. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Hegde VL; Nagarkatti PS; Nagarkatti M
PLoS One; 2011 Apr; 6(4):e18281. PubMed ID: 21483776
[TBL] [Abstract][Full Text] [Related]
16. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
17. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling.
Kido M; Watanabe N; Okazaki T; Akamatsu T; Tanaka J; Saga K; Nishio A; Honjo T; Chiba T
Gastroenterology; 2008 Oct; 135(4):1333-43. PubMed ID: 18651994
[TBL] [Abstract][Full Text] [Related]
18. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
Christen U; Hintermann E
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916939
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2D6 as a model antigen.
Christen U; Holdener M; Hintermann E
Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
